CACNA1H / Cav3.2, Polyclonal Antibody

Rabbit Polyclonal to Human CACNA1H / Cav3.2; Human CACNA1H / Cav3.2; Alpha 1h; Cav3.2; CACNA1HB; EIG6; MNCb-1209; ECA6

For Research Use Only. Not for use in diagnostic procedures.

Polyclonal

Rabbit

CACNA1H antibody is human, mouse and rat reactive. Multiple isoforms of CACNA1H are known to exist.

Immunoaffinity purified

PBS, 0.02% sodium azide.

1 mg/ml (lot specific)

Long term: -20 degree C
Short term: 4 degree C
Avoid repeat freeze-thaw cycles

Small volumes of anti-CACNA1H antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

CACNA1H Antibody, Alpha 1h Antibody, Cav3.2 Antibody, CACNA1HB Antibody, EIG6 Antibody, MNCb-1209 Antibody, ECA6 Antibody Description: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1H gives rise to T-type calcium currents. T-type calcium channels belong to the "low-voltage activated (LVA)" group and are strongly blocked by nickel and mibefradil.

Immunohistochemistry (IHC) Paraffin, Immunofluorescence (IF), Western Blot (WB), ELISA (EIA)

IF (20 ug/ml)
IHC-P (10 ug/ml)
WB (1 - 2 ug/ml)

Immunohistochemistry of CACNA1H in mouse brain tissue with CACNA1H antibody at 5 ug/ml.

Human Testis: Formalin-Fixed, Paraffin-Embedded (FFPE)

Human Heart: Formalin-Fixed, Paraffin-Embedded (FFPE)

Immunofluorescence of CACNA1H in mouse brain tissue with CACNA1H antibody at 20 ug/ml.

258,545 Da

calcium voltage-gated channel subunit alpha1 H

voltage-dependent T-type calcium channel subunit alpha-1H

Voltage-dependent T-type calcium channel subunit alpha-1H

CAC1H_HUMAN

This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

CACNA1H: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1H gives rise to T-type calcium currents. T-type calcium channels belong to the low-voltage activated (LVA) group and are strongly blocked by nickel and mibefradil. A particularity of this type of channels is an opening at quite negative potentials, and a voltage-dependent inactivation. T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle. They may also be involved in the modulation of firing patterns of neurons which is important for information processing as well as in cell growth processes. Defects in CACNA1H are a cause of susceptibility to epilepsy, idiopathic generalized type 6 (EIG6). A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. EIG6 is a polygenic and multifactorial disease. Defects in CACNA1H are a cause of susceptibility to epilepsy, childhood absence type 6 (ECA6). A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic- clonic seizures often develop in adolescence. Absence seizures may either remit or persist into *****hood. Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family. CACNA1H subfamily. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Membrane protein, multi-pass; Cell development/differentiation; Membrane protein, integral; Channel, calcium

Chromosomal Location of Human Ortholog: 16p13.3

Cellular Component: caveola; integral to membrane; sarcolemma; voltage-gated calcium channel complex

Molecular Function: low voltage-gated calcium channel activity; metal ion binding

Biological Process: aldosterone biosynthetic process; axon guidance; cellular response to hormone stimulus; muscle contraction; muscle development; myoblast fusion; regulation of heart contraction; regulation of membrane potential; transport

Disease: Epilepsy, Childhood Absence, Susceptibility To, 6

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.